IC14

· Implicit Bioscience

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for IC14, covering 2017-05-16 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy [Phase 1, Phase 2]